- Home
- ATOS vs MGYR Comparison
ATOS vs MGYR Comparison
Compare ATOS & MGYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATOS
- MGYR
- Stock Information
- Founded
- ATOS 2009
- MGYR 1922
- Country
- ATOS United States
- MGYR United States
- Employees
- ATOS 10
- MGYR N/A
- Industry
- ATOS Biotechnology: Pharmaceutical Preparations
- MGYR Savings Institutions
- Sector
- ATOS Health Care
- MGYR Finance
- Exchange
- ATOS Nasdaq
- MGYR Nasdaq
- Market Cap
- ATOS 114.5M
- MGYR 94.2M
- IPO Year
- ATOS 2012
- MGYR 2006
- Fundamental
- Price
- ATOS $0.96
- MGYR $14.67
- Analyst Decision
- ATOS Strong Buy
- MGYR
- Analyst Count
- ATOS 3
- MGYR 0
- Target Price
- ATOS $7.00
- MGYR N/A
- AVG Volume (30 Days)
- ATOS 826.7K
- MGYR 1.7K
- Earning Date
- ATOS 11-12-2024
- MGYR 01-31-2025
- Dividend Yield
- ATOS N/A
- MGYR 1.65%
- EPS Growth
- ATOS N/A
- MGYR 2.28
- EPS
- ATOS N/A
- MGYR 1.23
- Revenue
- ATOS N/A
- MGYR $31,497,000.00
- Revenue This Year
- ATOS N/A
- MGYR N/A
- Revenue Next Year
- ATOS N/A
- MGYR N/A
- P/E Ratio
- ATOS N/A
- MGYR $11.78
- Revenue Growth
- ATOS N/A
- MGYR 4.87
- 52 Week Low
- ATOS $0.77
- MGYR $10.30
- 52 Week High
- ATOS $2.31
- MGYR $14.74
- Technical
- Relative Strength Index (RSI)
- ATOS 39.54
- MGYR 58.43
- Support Level
- ATOS $0.81
- MGYR $13.95
- Resistance Level
- ATOS $0.94
- MGYR $14.65
- Average True Range (ATR)
- ATOS 0.05
- MGYR 0.17
- MACD
- ATOS 0.01
- MGYR -0.01
- Stochastic Oscillator
- ATOS 39.13
- MGYR 98.80
About ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary innovative medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.
About MGYR Magyar Bancorp Inc.
Magyar Bancorp Inc is a mid-tier stock holding company. The Company offers a full array of commercial and retail financial services, including the taking of time, savings and demand deposits; the making of commercial, consumer and home equity loans; and the provision of other financial services. The business consists of getting retail deposits from the general public in the areas surrounding the main office in New Brunswick, New Jersey and branch offices located in Middlesex and Somerset Counties, New Jersey, and investing those deposits, together with funds generated from operations and wholesale funding, in residential mortgage loans, home equity loans, home equity lines of credit, commercial real estate loans, commercial business loans, Small Business Administration loans.